Concepedia

Author

Hirotsugu Sakaki

Yamagata University

Also Known As

HIROTSUGU SAKAKI, Hirotsugu Sakaki

18

Publications

389

Citations

10

H-Index

25

Concepts

All Affiliations

Yamagata University
HS

About

Hirotsugu Sakaki is an author at Yamagata University specializing in tumor biology, cancer research, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

95

2

Cell Biology

2

2

95

3

Pharmacology

2

2

95

4

Cancer Cell Biology

2

2

95

5

Health Sciences

1

1

58

Hirotsugu Sakaki

×

9

Publications

358

Citations

9

H-Index

YearCitations

The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>

Masashi Okada, Kenta Kuramoto, Hiroyuki Takeda,

Oncotarget

2016

58

GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.

Hirotsugu Sakaki, Masashi Okada, Kenta Kuramoto,

PubMed

2015

55

Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance

Shuhei Suzuki, Masashi Okada, Kenta Kuramoto,

Anticancer Research

2016

52

Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents

Tomomi Sanomachi, Shuhei Suzuki, Kenta Kuramoto,

Anticancer Research

2017

39

Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction

Kenta Kuramoto, Shuhei Suzuki, Hirotsugu Sakaki,

FEBS Open Bio

2017

37

Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug

Masashi Okada, Hiroyuki Takeda, Hirotsugu Sakaki,

Oncotarget

2017

37

Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine

Hiroyuki Takeda, Masashi Okada, Shuhei Suzuki,

Anticancer Research

2016

34

Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel

Manabu Seino, Masashi Okada, Hirotsugu Sakaki,

Oncology Reports

2015

25

Antitumor activity of gemcitabine against high-grade meningioma<i>in vitro</i>and<i>in vivo</i>

Hiroyuki Takeda, Masashi Okada, Kenta Kuramoto,

Oncotarget

2017

21

Page 1